OrderlyMeds Review 2026: Cost, Pros & Cons, Honest Verdict
OrderlyMeds shows up constantly in Reddit provider-comparison threads, yet there's surprisingly little thorough review coverage of it. This honest 2026 review covers OrderlyMeds' verified July 2026 pricing ($149/mo compounded semaglutide, $299/mo compounded tirzepatide at standard rates, with two-month starter offers), what's included, its Trustpilot record, real pros and cons, and how it compares to Trimi.
Quick answer
Yes. OrderlyMeds is a legitimate telehealth provider offering compounded GLP-1 medications through licensed prescribers, with a transparent pricing page, two-month starter offers, and no membership fees. Our verdict: solid intro pricing, but the standard rates, especially $299/mo compounded tirzepatide, run mid-to-high, it does not publicly name its compounding pharmacies, and its Trustpilot record is a mixed 3.7/5. Trimi offers flat all-inclusive pricing at $99/mo (semaglutide) and $125/mo (tirzepatide) on the annual plan, and names its pharmacies.
Verdict snapshot, is OrderlyMeds worth it?
OrderlyMeds is legit and its two-month starter offers are among the most aggressive intro deals in compounded GLP-1. The catch comes after the starter: standard rates of $149/mo for semaglutide and especially $299/mo for tirzepatide put the ongoing cost mid-to-high for the category, and OrderlyMeds does not name its pharmacy partners publicly. Trimi Health offers the same all-inclusive, same-price-per-dose model at a flat $99/mo (semaglutide) or $125/mo (tirzepatide) on the annual plan, with named 503A pharmacies and a published license number. For the broader landscape, see our best GLP-1 telehealth alternative guide.
More on GLP-1 Provider Comparisons
What Is OrderlyMeds?
OrderlyMeds (orderlymeds.com) is a direct-to-consumer telehealth platform for GLP-1 weight management. You complete an online eligibility assessment, a licensed provider reviews your health history, and, if a compounded GLP-1 is appropriate, your medication ships to your door with the syringes and alcohol pads included. It offers compounded semaglutide and compounded tirzepatide (which it markets as GLP-1/GIP), and, for patients who prefer the FDA-approved products, brand-name Wegovy and Zepbound pens at cash-pay prices. In 2026 it also announced an oral semaglutide option.
Two things stand out about OrderlyMeds' positioning. First, its pricing page is genuinely public and specific, starter totals and ongoing monthly rates are published, which beats the quote-at-checkout opacity some platforms use. Second, its intro offers are aggressive: two-month starters at $149 (semaglutide) and $299 (tirzepatide) work out to roughly half the standard monthly rate while they last. The full-price months that follow are where the value question gets more interesting, and where this review focuses.
Because Trimi is a competitor in the same compounded semaglutide and tirzepatide category, we flag our perspective openly, evaluate OrderlyMeds on its own merits first, and keep every claim tied to what we could verify in July 2026.
How OrderlyMeds Works
Online assessment: You complete an eligibility questionnaire covering weight history, health conditions, and medications.
Provider review: A licensed prescriber reviews your intake and determines whether a compounded GLP-1 is appropriate for you.
Prescription & compounding: If approved, your medication is prepared and shipped, OrderlyMeds says orders ship within 24 hours of approval.
Delivery: OrderlyMeds quotes a typical 5-6 business days start to finish, with syringes and alcohol pads included in the shipment.
Ongoing care: Pricing is the same at every dose, with no membership fees; starter plans include all weekly doses for the period in one shipment.
This is the standard legitimate structure for the category. Trimi follows the same overall flow, with medication prepared through a 503A sterile compounding pharmacy and clinicians supplied via the Arora Health 50-state network.
OrderlyMeds Pricing (Verified July 2026)
These figures come directly from OrderlyMeds' public pricing page in July 2026. The structure is a discounted multi-week starter followed by a standard monthly rate, with the same price at every dose and no membership fees.
| Medication | Starter Offer | Standard Rate |
|---|---|---|
| Compounded Semaglutide | $149 for the first 2 months (~$74/mo effective) | $149/mo |
| Compounded Tirzepatide (GLP-1/GIP) | $299 for the first 2 months (~$149/mo effective) | $299/mo |
| Membership / consult fees | None | None, supplies and shipping included |
OrderlyMeds has also advertised longer-commitment plans with lower effective monthly rates on its treatment pages, so the exact number you see at checkout can vary with plan length. The honest read: the starter offers are excellent, the $149/mo standard semaglutide rate is mid-market, and the $299/mo standard tirzepatide rate is where the ongoing cost stacks up least favorably, it is more than double what some flat-price providers charge for the same category of compounded medication. For how flat pricing compares across providers, see our cost guide.
Pricing Note
Telehealth pricing changes over time, and OrderlyMeds' starter offers in particular have varied. These figures were taken from OrderlyMeds' pricing page in July 2026; always confirm the current starter terms and the post-starter monthly rate before enrolling.
What OrderlyMeds Does Well
Public, specific pricing: starter totals and standard monthly rates are published on a dedicated pricing page, no quote-at-checkout guesswork.
Aggressive starter offers: $149 (semaglutide) and $299 (tirzepatide) for the first two months are among the strongest intro deals in the category.
Same price at every dose: no dose-based price escalation, and no membership or hidden fees per its published policy.
Supplies included: syringes and alcohol pads ship with the medication, and starter plans arrive as one complete shipment.
Fast turnaround claims: shipping within 24 hours of provider approval and a typical 5-6 business days start to finish.
Brand-name option: patients who prefer the FDA-approved products can get Wegovy or Zepbound pens through the same platform at cash-pay prices.
Where OrderlyMeds Falls Short
Pharmacy partners are not named: OrderlyMeds refers generically to state-licensed pharmacies and FDA-registered facilities but does not publish a pharmacy name or license number you can independently verify.
Standard tirzepatide rate is high: $299/mo after the starter period is more than double what some flat-price providers charge for the same category of compounded medication.
Mixed review record: a 3.7/5 'Average' Trustpilot rating across roughly 480+ reviews as of July 2026, with recurring complaints about pharmacy or shipping delays and slow communication during medication transitions.
Starter-vs-standard gap: the roughly 50% jump from the starter's effective rate to the standard rate can surprise patients who budgeted off the intro price, know the post-starter number before you enroll.
OrderlyMeds Patient Outcomes
OrderlyMeds dispenses compounded semaglutide and tirzepatide, like most of the category; compounded preparations are prepared per individual prescription and are not FDA-approved as drugs, a distinction the FDA explains in its compounding Q&A, and one OrderlyMeds' own site discloses. The published weight-loss data comes from the FDA-approved products: semaglutide produced a mean ~14.9% body-weight reduction at 68 weeks (STEP 1, NEJM) and tirzepatide up to ~20.9% at the maximum dose at 72 weeks (SURMOUNT-1, NEJM). Individual results vary with dose, adherence, diet, activity, and the quality of clinical support.
Between legitimate providers, support is the differentiator, not the medication category. Reliable refills, responsive clinicians during dose changes, and side effect management keep patients on therapy long enough to see results, and the transition-period delays in OrderlyMeds' negative reviews are worth asking the company about directly before enrolling.
Our Verdict on OrderlyMeds
Our verdict: a legitimate provider with excellent intro pricing whose weak points are the ongoing tirzepatide rate, unnamed pharmacies, and a middling review record.
OrderlyMeds does the fundamentals right, licensed prescribers, published pricing, included supplies, no membership fees, and its two-month starters are genuinely strong deals. Over a full year of treatment, though, the $299/mo standard tirzepatide rate erodes the intro savings quickly, and the combination of unnamed pharmacy partners and a 3.7/5 Trustpilot average means you are trusting the platform more than you can independently verify.
Best for: patients who want a low-cost first two months on compounded semaglutide, or who want the option of brand-name pens on the same platform.
Worth comparing if: you plan to stay on therapy beyond the starter period, especially on tirzepatide, or you want to verify exactly which pharmacy compounds your medication. See our Polly review and TrimRx review for how OrderlyMeds' pricing sits against other providers.
The named-pharmacy alternative
Flat $99 or $125 a month, every month, and you know the pharmacy
If OrderlyMeds' starter pricing appeals but the $149/$299 standard rates and unnamed pharmacies give you pause, Trimi offers clinician-guided compounded semaglutide at $99/mo and tirzepatide at $125/mo on the annual plan, flat across all doses, all-inclusive (provider visits, medication, supplies, shipping), free overnight shipping once compounded, prepared by named 503A pharmacies, VialsRx (TX #35264) and GreenwichRx. Individual results vary.
Start your online visitOrderlyMeds vs Trimi
Both platforms use a same-price-per-dose, no-membership-fee model, so the comparison comes down to the ongoing monthly rate, transparency, and clinical infrastructure. Comparisons between the two come up regularly in Reddit provider threads; here is the side-by-side on the verifiable facts.
| Feature | OrderlyMeds | Trimi |
|---|---|---|
| Semaglutide (monthly) | $149/mo standard ($149 two-month starter) | $99/mo flat on annual plan (all-inclusive) |
| Tirzepatide (monthly) | $299/mo standard ($299 two-month starter) | $125/mo flat on annual plan (all-inclusive) |
| Semaglutide (annualized, standard rate) | ~$1,788/yr | $1,188/yr |
| Tirzepatide (annualized, standard rate) | ~$3,588/yr | $1,500/yr |
| Pricing model | Same price per dose, starter offer then standard rate | All-inclusive, flat across all doses, published rate |
| Pharmacy | Not publicly named (state-licensed pharmacies, FDA-registered facilities) | VialsRx (TX Board of Pharmacy #35264) + GreenwichRx, 503A, license published |
| Clinicians | Licensed providers (network not publicly detailed) | US-licensed clinicians via Arora Health (50-state network, named Medical Director) |
| Trustpilot (July 2026) | 3.7/5 across ~480+ reviews | Not the basis of this comparison, see our reviews page for verifiable sources |
| Delivery | Ships within 24h of approval; 5-6 business days typical overall | Free overnight shipping (once compounded) |
The savings, in dollars
Semaglutide: Trimi ($99/mo flat) vs OrderlyMeds ($149/mo standard) saves about $50/mo, roughly $600/yr, or ~34% less at the standard rate.
Tirzepatide: Trimi ($125/mo flat) vs OrderlyMeds ($299/mo standard) saves about $174/mo, roughly $2,088/yr, or ~58% less at the standard rate.
Starter math: OrderlyMeds' two-month starters are cheaper than Trimi for those first two months; from month three onward, Trimi's flat rate is lower every month.
Same category of compounded medication, same no-membership structure, and a materially lower ongoing cost, plus a pharmacy you can verify: VialsRx's Texas State Board of Pharmacy license #35264 can be confirmed directly through the Texas State Board of Pharmacy. For the full landscape, see our best GLP-1 telehealth alternative guide and cost guide.
Switching from OrderlyMeds? Start Trimi in 10 minutes.
Same compounded GLP-1 medication, better value, compounded semaglutide as low as $99/mo or tirzepatide as low as $125/mo, all-inclusive (medication, US-licensed clinician via the Arora Health 50-state network, dose changes, refills, and free shipping). No contracts, cancel anytime, most OrderlyMeds patients cut the standard tirzepatide rate by ~58%.
Bottom Line
OrderlyMeds is a legitimate compounded-GLP-1 telehealth provider with published pricing, strong two-month starter offers, included supplies, and no membership fees. The honest caveats are what comes after the starter, $149/mo semaglutide is mid-market and $299/mo tirzepatide is expensive for the category, plus unnamed pharmacy partners and a mixed 3.7/5 Trustpilot record. If you enroll, budget off the standard rate, not the intro price. If you want the same model with a flat lower rate and a pharmacy you can verify by license number, compare Trimi at $99/mo (semaglutide) or $125/mo (tirzepatide) on the annual plan, and see our Polly review for another heavily advertised newcomer in the same space.
Frequently Asked Questions
Is OrderlyMeds legit?
Yes. OrderlyMeds is a legitimately operating telehealth provider offering compounded GLP-1 medications through licensed prescribers, with a transparent public pricing page, two-month starter offers, and no membership fees. The main cautions for shoppers: OrderlyMeds does not publicly name its compounding pharmacy partners, its standard $299/mo compounded tirzepatide rate is on the higher side, and its Trustpilot record is a mixed 3.7/5 as of July 2026.
How much does OrderlyMeds cost per month?
As of July 2026, OrderlyMeds' pricing page lists compounded semaglutide at a $149 two-month starter (about $74/mo effective), then $149/mo, and compounded tirzepatide at a $299 two-month starter (about $149/mo effective), then $299/mo. OrderlyMeds has also advertised longer-commitment plans with lower effective rates on its treatment pages. Prices are the same at every dose with no membership fees. By comparison, Trimi charges a flat $99/mo for compounded semaglutide and $125/mo for compounded tirzepatide on the annual plan, all-inclusive.
What medications does OrderlyMeds offer?
OrderlyMeds offers compounded semaglutide (injectable, with an oral option announced in 2026) and compounded tirzepatide (marketed as GLP-1/GIP), plus brand-name Wegovy and Zepbound pens at cash-pay prices for patients who prefer the FDA-approved products. Compounded preparations are prepared per individual prescription and are not FDA-approved as drugs, a disclaimer OrderlyMeds itself carries.
What pharmacy does OrderlyMeds use?
OrderlyMeds does not publicly name its compounding pharmacy partners. Its site refers generically to state-licensed pharmacies and FDA-registered facilities, without a pharmacy name or license number you can independently verify. That is not unusual in this market, but it is a transparency gap: Trimi, by contrast, names its 503A partners, VialsRx (Texas State Board of Pharmacy license #35264) and GreenwichRx.
What do OrderlyMeds reviews say?
As of July 2026, OrderlyMeds holds a 3.7/5 'Average' rating on Trustpilot across roughly 480+ reviews. Positive reviews highlight responsive customer service, easy reorders, and fast shipping; negative reviews most often describe pharmacy or shipping delays and slower communication during medication or dose transitions. It also comes up regularly in Reddit provider-comparison threads with similarly mixed, generally workable experiences.
How does OrderlyMeds compare to Trimi?
Both are legitimate compounded GLP-1 telehealth providers with same-price-per-dose models and no membership fees. The practical differences: price, Trimi's flat $99/mo semaglutide and $125/mo tirzepatide (annual plan) versus OrderlyMeds' standard $149/$299 monthly rates, and transparency, Trimi names its 503A pharmacies and publishes VialsRx's license number, while OrderlyMeds does not name its pharmacy partners. Trimi's clinician network (Arora Health) covers all 50 states with a publicly named Medical Director.
Sources & References
- OrderlyMeds. Official pricing page (orderlymeds.com/pricing). Verified July 2026.
- OrderlyMeds. Compounded GLP-1/GIP treatment pages (orderlymeds.com). Verified July 2026.
- Trustpilot. OrderlyMeds customer reviews. Accessed July 2026.
- STEP 1 trial: semaglutide in adults with overweight or obesity (NEJM, 2021).
- SURMOUNT-1 trial: tirzepatide for obesity (PubMed).
- FDA guidance on compounding and the FDA.
Medical Disclaimer: This content is for informational purposes only and is not medical advice, consult a licensed clinician before starting, stopping, or switching GLP-1 therapy. Compounded medications are prepared per individual prescription and are not FDA-approved as drugs. GLP-1 medications carry risks including nausea, pancreatitis, gallbladder disease, kidney injury, and a boxed warning for thyroid C-cell tumors. OrderlyMeds and Trimi are separate, unaffiliated companies; this review reflects Trimi's competitive perspective and aims to represent OrderlyMeds fairly and accurately based on information verified in July 2026.